Sandbox Reserved 1470
From Proteopedia
(Difference between revisions)
Line 11: | Line 11: | ||
== Structural highlights == | == Structural highlights == | ||
- | The <scene name='79/799598/Secondary_structure_of_kgp/2'>secondary structure</scene> of KGP is made up of about equal amounts of alpha helices and antiparallel beta sheets. The secondary structure is important to understand because it provides detail about how the protein is folded due to interactions between amino acids. For example, alpha helices shown in pink contain hydrophilic amino acids facing the solvent (outside) and hydrophobic amino acids facing inside, but the center of the helices is too small for even a hydrogen atom to fit through. Alpha helices and beta sheets cannot contain proline or glycine in their structure, so by simply knowing what the secondary structures are you already have insight into what types of amino acids are found in certain areas of the protein. For KGP, the secondary structure elements are generally connected by tight loops. The structure of KGP is broken up into a catalytic domain and an IGSF. The globular CD contains four cation binding sites (two sodium and two calcium ions) that generally contribute to the integrity of the<scene name='79/799598/Tertiary_structure/2'> tertiary structure</scene>. It is subdivided into a smaller A subdomain that contains the N-terminus which is highlighted in pink. It also contains a larger B subdomain that contains the C-terminus which is shown in orange. The light blue portion of the protein represents the IGSF, which is essential for folding of KGP. The IGSF fold corresponds to typical IGSF like domains, which usually function as cell adhesion molecules. By viewing KGP under the <scene name='79/799598/Space_fill_without_hydrophob/1'>space fill</scene> view you can see that the protein is very tightly packed and there is little to no room for other molecules to reach the center. The <scene name='79/799598/Space_fill_view/2'>hydrophibictity</scene> view of KGP shows the protein contains both hydrophilic, shown in pink, and hydrophobic, shown in grey, amino acid residues. The red molecules represent the solvent. The<scene name='79/799598/Ckc_ligand/2'> ligand</scene> 'CKC' is a lysine mimic that binds to KGP and is recognized by the cysteine peptidase to cleave Lys-X. KGP contains a <scene name='79/799598/Triad_interacting_with_ckc/2'>catalytic triad</scene>: Cys-477, His-444, Asp-388. The catalytic triad interacts with the ligand CKC. Histidine and aspartic acid use acid base chemistry catalysis to form a covalent intermediate with Cysteine 477. The intermediate formed is L-lysinylmethyl (LM) group in the specificity pocket. The <scene name='79/799598/Active_site/1'>active site</scene> is shown with the catalytic triad in red, and other amino acid residues that interact in the specificity pocket. KGP contains a set of alpha helices that are interrupted by a <scene name='79/799598/Interrupted_alpha_helices/1'>segment</scene> of the protein that contains glycine and proline amino acids. These residues, highlighted in red, are alpha helix breakers as glycine is too small and proline contains a ring structure that prevents the alpha helix from forming. These interrupted alpha helices are exceedingly rare in protein structures. CSD domain of the protein contains an internal channel that vertically traverses the molecule over 20 Angstroms from the bottom of the specificity pocket in the active site to the lower outer surface of the subdomain. The channel emerges through a <scene name='79/799598/Internal_channel_amino_acids/1'>crater</scene> surrounded by the amino acids shown in the JSmol. KGP interacts with various <scene name='79/799598/Ion_site_of_ca998/1'>ions</scene> through solvent channels. This JSmol shows various amino acid residues interacting with a calcium ion. | + | The <scene name='79/799598/Secondary_structure_of_kgp/2'>secondary structure</scene> of KGP is made up of about equal amounts of alpha helices and antiparallel beta sheets. The secondary structure is important to understand because it provides detail about how the protein is folded due to interactions between amino acids. For example, alpha helices shown in pink contain hydrophilic amino acids facing the solvent (outside) and hydrophobic amino acids facing inside, but the center of the helices is too small for even a hydrogen atom to fit through. Alpha helices and beta sheets cannot contain proline or glycine in their structure, so by simply knowing what the secondary structures are you already have insight into what types of amino acids are found in certain areas of the protein. For KGP, the secondary structure elements are generally connected by tight loops. The structure of KGP is broken up into a catalytic domain and an IGSF. The globular CD contains four cation binding sites (two sodium and two calcium ions) that generally contribute to the integrity of the<scene name='79/799598/Tertiary_structure/2'> tertiary structure</scene>. It is subdivided into a smaller A subdomain that contains the N-terminus which is highlighted in pink. It also contains a larger B subdomain that contains the C-terminus which is shown in orange. The light blue portion of the protein represents the IGSF, which is essential for folding of KGP. The IGSF fold corresponds to typical IGSF like domains, which usually function as cell adhesion molecules. By viewing KGP under the <scene name='79/799598/Space_fill_without_hydrophob/1'>space fill</scene> view you can see that the protein is very tightly packed and there is little to no room for other molecules to reach the center. The <scene name='79/799598/Space_fill_view/2'>hydrophibictity</scene> view of KGP shows the protein contains both hydrophilic, shown in pink, and hydrophobic, shown in grey, amino acid residues. The red molecules represent the solvent. The<scene name='79/799598/Ckc_ligand/2'> ligand</scene> 'CKC' is a lysine mimic that binds to KGP and is recognized by the cysteine peptidase to cleave Lys-X. KGP contains a <scene name='79/799598/Triad_interacting_with_ckc/2'>catalytic triad</scene>: Cys-477, His-444, Asp-388. The catalytic triad interacts with the ligand CKC, shown highlighted in red in the scene. Histidine and aspartic acid use acid base chemistry catalysis to form a covalent intermediate with Cysteine 477. The intermediate formed is L-lysinylmethyl (LM) group in the specificity pocket. The <scene name='79/799598/Active_site/1'>active site</scene> is shown with the catalytic triad in red, and other amino acid residues that interact in the specificity pocket. KGP contains a set of alpha helices that are interrupted by a <scene name='79/799598/Interrupted_alpha_helices/1'>segment</scene> of the protein that contains glycine and proline amino acids. These residues, highlighted in red, are alpha helix breakers as glycine is too small and proline contains a ring structure that prevents the alpha helix from forming. These interrupted alpha helices are exceedingly rare in protein structures. CSD domain of the protein contains an internal channel that vertically traverses the molecule over 20 Angstroms from the bottom of the specificity pocket in the active site to the lower outer surface of the subdomain. The channel emerges through a <scene name='79/799598/Internal_channel_amino_acids/1'>crater</scene> surrounded by the amino acids shown in the JSmol. KGP interacts with various <scene name='79/799598/Ion_site_of_ca998/1'>ions</scene> through solvent channels. This JSmol shows various amino acid residues interacting with a calcium ion. |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> |
Revision as of 16:34, 26 November 2018
This Sandbox is Reserved from October 22, 2018 through April 30, 2019 for use in the course Biochemistry taught by Bonnie Hall at the Grand View University, Des Moines, IA USA. This reservation includes Sandbox Reserved 1456 through Sandbox Reserved 1470. |
To get started:
More help: Help:Editing |
Structure and Mechanism of Cysteine Peptidase Gingipain K (KGP), a Major Virulence Factor of Porphyromonas gingivitis in Periodontitis
|
References
- ↑ de Diego I, Veillard F, Sztukowska M, Guevara T, Potempa B, Pomowski A, Huntington JA, Potempa J, Gomis-Ruth FX. Structure and mechanism of cysteine peptidase Kgp, a major virulence factor of Porphyromonas gingivalis in periodontitis. J Biol Chem. 2014 Sep 29. pii: jbc.M114.602052. PMID:25266723 doi:http://dx.doi.org/10.1074/jbc.M114.602052
- ↑ Yongqing T, Potempa J, Pike RN, Wijeyewickrema LC. The lysine-specific gingipain of Porphyromonas gingivalis : importance to pathogenicity and potential strategies for inhibition. Adv Exp Med Biol. 2011;712:15-29. doi: 10.1007/978-1-4419-8414-2_2. PMID:21660656 doi:http://dx.doi.org/10.1007/978-1-4419-8414-2_2
- ↑ Tilakaratne A, Soory M. Anti-inflammatory Actions of Adjunctive Tetracyclines and Other Agents in Periodontitis and Associated Comorbidities. Open Dent J. 2014 May 30;8:109-24. doi: 10.2174/1874210601408010109. eCollection , 2014. PMID:24976875 doi:http://dx.doi.org/10.2174/1874210601408010109
- ↑ Kurita-Ochiai T, Yamamoto M. Periodontal pathogens and atherosclerosis: implications of inflammation and oxidative modification of LDL. Biomed Res Int. 2014;2014:595981. doi: 10.1155/2014/595981. Epub 2014 May 18. PMID:24949459 doi:http://dx.doi.org/10.1155/2014/595981
- ↑ Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, Gawron K, Mizgalska D, Marcinska KA, Benedyk M, Pyrc K, Quirke AM, Jonsson R, Alzabin S, Venables PJ, Nguyen KA, Mydel P, Potempa J. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog. 2013 Sep;9(9):e1003627. doi: 10.1371/journal.ppat.1003627. Epub 2013, Sep 12. PMID:24068934 doi:http://dx.doi.org/10.1371/journal.ppat.1003627
- ↑ Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, Leonard P, Li J, Burgdorf K, Grarup N, Jorgensen T, Brandslund I, Nielsen HB, Juncker AS, Bertalan M, Levenez F, Pons N, Rasmussen S, Sunagawa S, Tap J, Tims S, Zoetendal EG, Brunak S, Clement K, Dore J, Kleerebezem M, Kristiansen K, Renault P, Sicheritz-Ponten T, de Vos WM, Zucker JD, Raes J, Hansen T, Bork P, Wang J, Ehrlich SD, Pedersen O. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013 Aug 29;500(7464):541-6. doi: 10.1038/nature12506. PMID:23985870 doi:http://dx.doi.org/10.1038/nature12506
- ↑ May M. Drug development: Time for teamwork. Nature. 2014 May 1;509(7498):S4-5. doi: 10.1038/509S4a. PMID:24784427 doi:http://dx.doi.org/10.1038/509S4a
- ↑ Hede K. Antibiotic resistance: An infectious arms race. Nature. 2014 May 1;509(7498):S2-3. doi: 10.1038/509S2a. PMID:24784426 doi:http://dx.doi.org/10.1038/509S2a